Related Experiment Video
Updated: Apr 20, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable
Alana M Munger1, Dominic C Chow, Martin P Playford
11 Hawaii Center for AIDS, University of Hawaii , Honolulu, Hawaii.
Insights
Individuals with HIV on stable antiretroviral therapy show an atherogenic lipoprotein profile, with increased LDL particle number and reduced HDL function, despite normal traditional lipid panels. This highlights the need for advanced lipid testing in HIV patients to assess cardiovascular disease risk.
Area of Science:
- Cardiovascular Disease Research
- Lipid Metabolism and Atherosclerosis
- HIV/AIDS Pathophysiology
Background:
- Increased cardiovascular disease (CVD) morbidity is observed in individuals with HIV.
- Traditional lipid measures may not fully capture the inflammatory lipid modulation contributing to CVD risk in HIV.
- Advanced lipoprotein phenotyping is crucial for a comprehensive risk assessment.
Purpose of the Study:
- To conduct advanced lipoprotein phenotyping in HIV-infected patients on stable antiretroviral therapy (ART).
- To assess high-density lipoprotein (HDL) cholesterol efflux capacity, and lipoprotein particle concentration and size.
- To determine associations between advanced lipoprotein parameters and cardiometabolic risk factors.
Main Methods:
- Study included 118 well-phenotyped patients infected with HIV on stable ART.
- Advanced lipoprotein phenotyping using NMR spectroscopy.
- Analysis of HDL cholesterol efflux capacity, lipoprotein particle number, and size.
- Simple and multivariable regression analyses were performed.
Main Results:
- Participants had normal traditional lipid panels but demonstrated an atherogenic profile via advanced testing.
- Elevated LDL particle number (median 1,233 nmol/L) and decreased LDL size (median 20.4 nm) were observed.
- Reduced large HDL particles (median 3.15 μmol/L) and diminished HDL cholesterol efflux capacity were noted.
- HDL efflux capacity correlated with HDL levels, small LDL particle concentration, insulin sensitivity (Matsuda index), and Framingham Risk Score.
Conclusions:
- HIV-infected patients on stable ART exhibit an atherogenic lipoprotein profile, characterized by altered LDL and HDL parameters, despite normal conventional lipid levels.
- Advanced lipoprotein phenotyping and HDL efflux capacity assessment are vital for accurate CVD risk stratification in this population.
- These findings underscore the complex interplay between HIV, ART, lipid metabolism, and cardiovascular risk.
Abstract:
There is an increase in the cardiovascular disease (CVD) morbidity in individuals infected with HIV that may be due to inflammatory lipid modulation not captured by traditional lipid measures. The objective of this study was to perform advanced lipoprotein phenotyping inclusive of the high-density lipoprotein (HDL) cholesterol efflux capacity and lipoprotein particle concentration and size in a well-phenotyped group of 118 patients infected with HIV. We used simple and multivariable analyses to determine the associations between advanced lipoprotein parameters and known cardiometabolic risk factors. Participants were on stable antiretroviral therapy (ART) and had benign traditional lipid panels [median total cholesterol, low-density lipoprotein (LDL)-C, HDL-C, and triglycerides of 178 mg/dl, 108 mg/dl, 44 mg/dl, and 122.5 mg/dl, respectively]. However, advanced lipoprotein phenotyping demonstrated an elevation of LDL particle number (median of 1,233 nmol/liter) and a decrease in LDL size (median of 20.4 nm), along with a decrease in protective, large HDL particles (median of 3.15 μmol/liter) and reduced HDL cholesterol efflux capacity in comparison to controls of other studies. HDL cholesterol efflux capacity was associated with HDL levels (β=0.395, p<0.001), small LDL particle concentration (β=-0.198, p=0.031), insulin sensitivity by the Matsuda index (β=0.218, p=0.029), and the Framingham Risk Score (β=-0.184, p=0.046). We demonstrate an atherogenic lipoprotein profile by NMR spectroscopy and HDL efflux measurement in a group of HIV-infected patients on stable ART with normal lipid panels.
Related Concept Videos
Retrovirus Life Cycles
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Size and Structure of Viral Genomes

